₹82.23
0.00%NSE close, 16 Nov 2026
+98.53%
Shukra Pharmaceuticals is a small cap company, listed on NSE under the symbol SHUKRAPHAR. At ₹82.23 a share, the market values the whole company at ₹3,615 crore.
Promoters hold 51.15% of the shares. Foreign institutions hold 0.44%, and domestic institutions, mutual funds among them, 0.22%.
₹ crore. Consolidated figures.
| Line | Sep 2026 |
|---|---|
| Sales | 44.2 |
| Expenses | 25.5 |
| Operating profit | 18.7 |
| Operating margin | 42.3% |
| Other income | 0.6 |
| Interest | 0.3 |
| Depreciation | 1.1 |
| Profit before tax | 17.8 |
| Tax | 5.1 |
| Net profit | 12.7 |
| EPS (₹) | 0.29 |
The name has been changed from
Newspaper Publication of Quarterly Results
Media Release
The financial results for the period ended September 30, 2026.
₹ crore, financial years to March.
Not filed yet.
₹ crore, at each year's end and the latest half year.
| Line | Sep 2026 |
|---|---|
| Shareholders’ equity | 118 |
| Borrowings | 22.5 |
| Total liabilities | 57.4 |
| Fixed assets | 20.9 |
| Investments | 0 |
| Cash and equivalents | 0 |
| Total assets | 175 |
₹ crore, by financial year, and the latest half year.
| Line | 6M to Sep 2026 |
|---|---|
| From operations | 0.4 |
| From investing | −15.3 |
| From financing | 19.9 |
| Spent on fixed assets | −15.6 |
| Free cash flow | −15.1 |
Margins, returns, debt, tax and cash.
Not filed yet.
SDD Reg 3(5) 3(6)
Outcome of Board Meeting held on October 06, 2026.
Significant movement in price has been observed in Shukra Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has…
A copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
Outcome of Board Meeting held on September 28, 2026.
Record date for the purpose of Dividend is 21-Sep-2026.
Notice of Annual General Meeting to be held on September 28, 2026